The stock's rise snapped a four-day losing streak.

Google Cloud is enhancing its Vertex AI search platform for healthcare with multimodal AI capabilities. Specifically, it will ...

Google Cloud today announced new generative AI (gen AI) capabilities in Vertex AI Search for healthcare, including a new feature called Visual Q&A that searches tables, charts, and diagrams, and the ...

We recently compiled a list of the 10 Worst Performing Software Stocks to Buy According to Analysts. In this article, we are ...

Following testing by DNV at a rooftop project in the Italian city of Milan during January, it concluded that Trinasolar’s ...

Stifel Nicolaus downgraded shares of Vertex (NASDAQ:VERX – Free Report) from a buy rating to a hold rating in a report ...

Vertex (NASDAQ:VERX – Free Report) had its target price trimmed by Jefferies Financial Group from $62.00 to $48.00 in a ...

Fintel reports that on February 28, 2025, Stifel downgraded their outlook for Vertex (NasdaqGM:VERX) from Buy to Hold.

Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...

To learn more about Counterpart Health, visit: www.counterparthealth.com.

Vertex Pharmaceuticals (VRTX) stock in focus as company secures EU backing to expand label for its cystic fibrosis therapy ...

Vertex has backed out of its in vivo gene editing collaboration with Verve Therapeuti | Vertex has backed out of its in vivo ...